BRAF Mutation-Related Tumors
3 clinical trials · Condition
◉ Watch BRAF Mutation-Related Tumors
| Record | Firm | Date |
|---|---|---|
| Study of Cemiplimab Combined With Dabrafenib and Trametinib in People With Anaplastic Thyroid Cancer (NCT04238624) | Memorial Sloan Kettering Cancer Center | 2020-01-20 |
Track BRAF Mutation-Related Tumors automatically
Every clearance here is in the API, with alerts when new ones post.